لوحة متابعة معلومات المشاركين

البرنامج العالمي حول الجينات المرتبطة بداء باركنسون GP2 هو برنامج مدته خمس سنوات يهدف إلى تحسين فهمنا للبنية الجينية لداء باركنسون، وذلك من خلال دراسة النماذج الوراثية لمجموعات متنوعة من المرضى بالإضافة إلى الأشكال الوراثية النادرة للمرض. لا يزال أمامنا الكثير لنتعلمه حول عوامل الخطر الجينية، ويتطلب تطوير فهمنا لهذه العوامل التعاون المنفتح، ومشاركة البيانات والإجراءات والنتائج. ننصحك بزيارة هذه الصفحة باستمرار للتأكد من أنك على علم ودراية بأحدث التغييرات.

إجمالي البيانات العالمية

مواقع منفردة

مجموعات البحث

العينات المتوقعة

العينات التي تم الانتهاء منها

آخر تحديث: التصميم الأصلي ل GP2 قام به فريق هاكاثون 9, 2021 New_-Anastasia-Illarionova-150x150

Showing 10 of 238 cohort studies.

C-OPN

University of Calgary/McGill University | Calgary, Canada

Access Data on AMP® PD

Number of Samples Completed and Expected

Case Samples

384 Completed out of 1,500 Expected

Non-PD Samples

0 Completed out of 0 Expected

Total Samples

384 Completed out of 1,500 Expected

Ancestry Breakdown for Samples Completed

Show

Ancestry	PD Cases	Healthy Controls	Parkinson's Adjacent Disorders	Prodomal	Total Non-PD Samples
aac - african admixed	0	0	0	Pending	0
afr - african ancestry	0	0	0	Pending	0
fin - finnish population isolate	2	0	0	Pending	0
aj - ashkenazi jewish	9	0	0	Pending	0
amr - latino and indigenous people of the americas	4	0	0	Pending	0
eur - general european ancestry	348	0	0	Pending	0
eas - east asian ancestry	6	0	0	Pending	0
sas - south asian ancestry	7	0	0	Pending	0
cas - central asian ancestry	0	0	0	Pending	0
mde - middle eastern ancestry	7	0	0	Pending	0
cah - complex admixture history	1	0	0	Pending	0
total	384	0	0	0	0
Total for all completed samples					384

CALYPSO

University College London | London, United Kingdom

Access Data on AMP® PD

Number of Samples Completed and Expected

Case Samples

179 Completed out of 400 Expected

Non-PD Samples

0 Completed out of 200 Expected

Total Samples

179 Completed out of 600 Expected

Ancestry Breakdown for Samples Completed

Show

Ancestry	PD Cases	Healthy Controls	Parkinson's Adjacent Disorders	Prodomal	Total Non-PD Samples
aac - african admixed	0	0	0	Pending	0
afr - african ancestry	2	0	0	Pending	0
fin - finnish population isolate	0	0	0	Pending	0
aj - ashkenazi jewish	1	0	0	Pending	0
amr - latino and indigenous people of the americas	0	0	0	Pending	0
eur - general european ancestry	173	0	0	Pending	0
eas - east asian ancestry	0	0	0	Pending	0
sas - south asian ancestry	1	0	0	Pending	0
cas - central asian ancestry	1	0	0	Pending	0
mde - middle eastern ancestry	0	0	0	Pending	0
cah - complex admixture history	1	0	0	Pending	0
total	179	0	0	0	0
Total for all completed samples					179

Cambridge Parkinson's Research Clinic

University of Cambridge | Cambridge, United Kingdom

Number of Samples Completed and Expected

Case Samples

0 Completed out of 250 Expected

Non-PD Samples

0 Completed out of 0 Expected

Total Samples

0 Completed out of 250 Expected

CamPaIGN

University of Cambridge | Cambridge, United Kingdom

Number of Samples Completed and Expected

Case Samples

0 Completed out of 142 Expected

Non-PD Samples

0 Completed out of 0 Expected

Total Samples

0 Completed out of 142 Expected

CANDAS

University College London | London, United Kingdom

Number of Samples Completed and Expected

Case Samples

0 Completed out of 244 Expected

Non-PD Samples

0 Completed out of 18 Expected

Total Samples

0 Completed out of 262 Expected

Central Asian and Transcaucasian PD (CAT-PD)

University College London | Almaty, Kazakhstan

Access Data on AMP® PD

Number of Samples Completed and Expected

Case Samples

319 Completed out of 200 Expected

Non-PD Samples

314 Completed out of 200 Expected

Total Samples

633 Completed out of 400 Expected

Ancestry Breakdown for Samples Completed

Show

Ancestry	PD Cases	Healthy Controls	Parkinson's Adjacent Disorders	Prodomal	Total Non-PD Samples
aac - african admixed	0	1	0	Pending	1
afr - african ancestry	0	0	0	Pending	0
fin - finnish population isolate	0	0	0	Pending	0
aj - ashkenazi jewish	0	0	0	Pending	0
amr - latino and indigenous people of the americas	0	19	0	Pending	19
eur - general european ancestry	16	33	0	Pending	33
eas - east asian ancestry	2	0	0	Pending	0
sas - south asian ancestry	0	0	0	Pending	0
cas - central asian ancestry	268	50	2	Pending	52
mde - middle eastern ancestry	12	183	2	Pending	185
cah - complex admixture history	21	24	0	Pending	24
total	319	310	4	0	314
Total for all completed samples					633

Central Asian and Transcaucasian PD (CAT-PD) - Avicena Tajik State Medical University

Avicena Tajik State Medical University | Dushanbe, Tajikistan

Number of Samples Completed and Expected

Case Samples

Pending

Non-PD Samples

Pending

Total Samples

0 Completed out of 0 Expected

Central Asian and Transcaucasian PD (CAT-PD) - Istanbul Klinic

Istanbul Klinic | Baku, Azerbaijan

Number of Samples Completed and Expected

Case Samples

Pending

Non-PD Samples

Pending

Total Samples

0 Completed out of 0 Expected

Central Asian and Transcaucasian PD (CAT-PD) - Kazakh National Medical University

Kazakh National Medical University | Almaty, Kazakhstan

Number of Samples Completed and Expected

Case Samples

Pending

Non-PD Samples

Pending

Total Samples

0 Completed out of 0 Expected

Central Asian and Transcaucasian PD (CAT-PD) - Somnus Movement Disorders Clinic

Somnus Movement Disorders Clinic | Yerevan, Armenia

Number of Samples Completed and Expected

Case Samples

Pending

Non-PD Samples

Pending

Total Samples

0 Completed out of 0 Expected

طلب مجموعة بيانات AMP-PD

بينما تكتمل عملية تصنيف النماذج الوراثية للمشاركين، تتم مشاركة كل بيانات GP2 من خلال منصة «تعزيز شراكة تطوير أدوية مرض باركنسون (AMP PD)» الآمنة. التسجيل لطلب الدخول إلى هذه البيانات

قدموا لنا مجموعة من الأشخاص للدراسة

إذا كنتم ترغبون بالتعاون مع البرنامج العالمي حول الجينات المرتبطة بداء باركنسون GP2، تواصلوا معنا للتقدم بمجموعة من المشاركين أو للحصول على المزيد من المعلومات حول كيفية الانضمام.

استكشفوا قائمة أعضاء البرنامج العالمي حول الجينات المرتبطة بداء باركنسون GP2 من حول العالم

استكشفوا قائمة المؤسسات المنضمة للبرنامج، والتي تجعل تنفيذ أبحاثنا ممكناً بفضل تعاونهم ومساهمتهم بالعينات والبيانات.